These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31495945)

  • 1. An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical application.
    Zhong B; Campagne O; Tinkle CL; Stewart CF
    Biomed Chromatogr; 2020 Jan; 34(1):e4697. PubMed ID: 31495945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.
    Ding X; Li F; McKnight J; Schmidt C; Strooisma K; Shimizu H; Faber K; Ware JA; Dean B
    J Pharm Biomed Anal; 2014 Nov; 100():150-156. PubMed ID: 25165011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-ESI-MS/MS determination of copanlisib, a novel PI3K inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice.
    Dittakavi S; Mullangi R
    Biomed Chromatogr; 2019 Apr; 33(4):e4460. PubMed ID: 30536684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
    Giri P; Joshi V; Giri S; Delvadia P; Jain MR
    Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0152 in human plasma using solid-phase extraction.
    Shin YG; Jones SA; Murakami SC; Budha N; Ware J; Wong H; Buonarati MH; Dean B; Hop CE
    Biomed Chromatogr; 2013 Jan; 27(1):102-10. PubMed ID: 22623056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of crizotinib in human and mouse plasma by liquid chromatography electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).
    Roberts MS; Turner DC; Broniscer A; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():151-7. PubMed ID: 24811158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalytical method development, validation and quantification of dorsomorphin in rat plasma by LC-MS/MS.
    Karthikeyan K; Mahat MY; Chandrasekaran S; Gopal K; Franklin PX; Sivakumar BJ; Singh G; Narayanan S; Gopalan B; Khan AA
    Biomed Chromatogr; 2013 Aug; 27(8):1018-26. PubMed ID: 23526253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).
    Roberts MS; Turner DC; Owens TS; Ramachandran A; Wetmore C; Throm SL; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():1-5. PubMed ID: 23644495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors.
    Zhong B; Campagne O; Salloum R; Purzner T; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122254. PubMed ID: 32615532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasma.
    Ding X; Chen Y; Sahasranaman S; Shi Y; McKnight J; Dean B
    Biomed Chromatogr; 2016 Dec; 30(12):1984-1991. PubMed ID: 27245274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitation.
    Shin YG; Jones SA; Murakami SC; Liu L; Wong H; Buonarati MH; Hop CE
    Biomed Chromatogr; 2012 Nov; 26(11):1444-51. PubMed ID: 22311651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
    Dilly Penchala S; Alagaratnam J; Challenger E; Amara A; Else L; Winston A; Khoo S
    Biomed Chromatogr; 2020 Jan; 34(1):e4711. PubMed ID: 31629375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of azasetron hydrochloride in rabbit plasma by liquid chromatography tandem mass spectrometry and its application.
    Lin G; Ma J; Zhu J; Yang X; Hu L; Wang X
    Biomed Chromatogr; 2011 Oct; 25(10):1107-11. PubMed ID: 21204117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
    Minocha M; Khurana V; Mitra AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():85-92. PubMed ID: 22749591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extraction.
    Chou B; Adler RS; Meng M; Percey S; Dean B; Hop CE; Shin YG
    J Pharm Biomed Anal; 2012 Nov; 70():354-61. PubMed ID: 22717139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative method for analysis of hydrocodone, hydromorphone and norhydrocodone in human plasma by liquid chromatography-tandem mass spectrometry.
    Valtier S; Mueck RL; Bebarta VS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():40-5. PubMed ID: 23523877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.
    Ding X; Faber K; Shi Y; McKnight J; Dorshorst D; Ware JA; Dean B
    J Pharm Biomed Anal; 2016 Jul; 126():117-23. PubMed ID: 27187764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies.
    Puttrevu SK; Laxman TS; Tripathi AK; Yadav AK; Verma SK; Mishra A; Pradhan R; Verma NK; Ghosh JK; Bhatta RS
    J Pharm Biomed Anal; 2019 May; 169():116-126. PubMed ID: 30851514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Cloretazine (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).
    Bai F; Minkin P; Fraga CH; O'Shaughnessy MA; Gururangan S; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):97-104. PubMed ID: 17446145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.